Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 9
2009 44
2010 100
2011 119
2012 166
2013 167
2014 205
2015 261
2016 221
2017 266
2018 292
2019 314
2020 355
2021 399
2022 389
2023 415
2024 480
2025 519
2026 234

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,285 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.
Zimmer JA, Sims JR, Evans CD, Nery ESM, Wang H, Wessels AM, Tronchin G, Sato S, Raket LL, Andersen SW, Sapin C, Paget MA, Gueorguieva I, Ardayfio P, Khanna R, Brooks DA, Matthews BR, Mintun MA; Alzheimer’s Disease Neuroimaging Initiative. Zimmer JA, et al. J Prev Alzheimers Dis. 2026 Feb;13(2):100446. doi: 10.1016/j.tjpad.2025.100446. Epub 2025 Dec 1. J Prev Alzheimers Dis. 2026. PMID: 41330788 Free PMC article. Clinical Trial.
Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks.
Petersen KK, Milà-Alomà M, Li Y, Du L, Xiong C, Tosun D, Saef B, Saad ZS, Du-Cuny L, Coomaraswamy J, Mordashova Y, Rubel CE, Meyers EA, Shaw LM, Dage JL, Ashton NJ, Zetterberg H, Ferber K, Triana-Baltzer G, Baratta M, Rosenbaugh EG, Cruchaga C, McDade E, Holtzman DM, Morris JC, Sabandal JM, Bateman RJ, Bannon AW, Potter WZ, Schindler SE; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team. Petersen KK, et al. Nat Med. 2026 Mar;32(3):1085-1094. doi: 10.1038/s41591-026-04206-y. Epub 2026 Feb 19. Nat Med. 2026. PMID: 41714746 Free PMC article.
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
Milà-Alomà M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, Dage JL, Du-Cuny L, Saad ZS, Saef B, Triana-Baltzer G, Raunig DL, Coomaraswamy J, Baratta M, Meyers EA, Mordashova Y, Rubel CE, Ferber K, Kolb H, Ashton NJ, Zetterberg H, Rosenbaugh EG, Sabandal M, Shaw LM, Bannon AW, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease Project Team. Milà-Alomà M, et al. Ann Neurol. 2025 Sep;98(3):508-523. doi: 10.1002/ana.27285. Epub 2025 Jun 20. Ann Neurol. 2025. PMID: 40539416 Free PMC article.
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease by impairing microglial function.
Pilat DJ, Le H, Prokopenko D, Lin CJ, Eimer WA, Quinti L, Gavrilles EP, Garcia SN, Heitman SN; Alzheimer’s Disease Neuroimaging Initiative (ADNI); McGinty D, Cetinbas M, Sadreyev RI, Tanzi RE, Griciuc A. Pilat DJ, et al. Neuron. 2026 Jan 7;114(1):46-66.e13. doi: 10.1016/j.neuron.2025.09.032. Epub 2025 Oct 17. Neuron. 2026. PMID: 41109213 Free PMC article.
Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers.
Cheng Y, He Y, Gopinath K, Billot B, Iglesias JE, Wu CY, Dodge H, Wills AM, Carlyle B, Kivisäkk P, Hyman BT, Arnold SE, Das S; Alzheimer’s Disease Neuroimaging Initiative and for the European Prevention of Alzheimer’s Disease (EPAD) Consortium. Cheng Y, et al. Brain Commun. 2025 May 30;7(3):fcaf210. doi: 10.1093/braincomms/fcaf210. eCollection 2025. Brain Commun. 2025. PMID: 40503330 Free PMC article.
Atrophy trajectories in Alzheimer's disease: how sex matters.
Inguanzo A, Poulakis K, Oltra J, Maioli S, Marseglia A, Ferreira D, Mohanty R, Westman E; Alzheimer’s Disease Neuroimaging Initiative. Inguanzo A, et al. Alzheimers Res Ther. 2025 Apr 11;17(1):79. doi: 10.1186/s13195-025-01713-x. Alzheimers Res Ther. 2025. PMID: 40217302 Free PMC article.
The effect of Alzheimer's disease genetic factors on limbic white matter microstructure.
Lorenz A, Sathe A, Zaras D, Yang Y, Durant A, Kim ME, Gao C, Newlin NR, Ramadass K, Kanakaraj P, Khairi NM, Li Z, Yao T, Huo Y, Dumitrescu L, Shashikumar N, Pechman KR, Jackson TB, Workmeister AW, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Habes M, Wang D, Tosun D, Toga AW, Thompson PM, Mormino EC, Zhang P, Schilling K; Alzheimer's Disease Neuroimaging Initiative (ADNI)The BIOCARD Study TeamThe Alzheimer's Disease Sequencing Project (ADSP); Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Bendlin B, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB. Lorenz A, et al. Alzheimers Dement. 2025 Apr;21(4):e70130. doi: 10.1002/alz.70130. Alzheimers Dement. 2025. PMID: 40219815 Free PMC article.
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease.
Pichet Binette A, Smith R, Salvadó G, Tideman P, Glans I, van Westen D, Groot C, Ossenkoppele R, Stomrud E, Parchi P, Zetterberg H, Blennow K, Mattsson-Carlgren N, Janelidze S, Palmqvist S, Hansson O; Alzheimer’s Disease Neuroimaging Initiative. Pichet Binette A, et al. JAMA Neurol. 2025 Jul 1;82(7):666-675. doi: 10.1001/jamaneurol.2025.1100. JAMA Neurol. 2025. PMID: 40388185 Free PMC article.
4,285 results